InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
4 hedge funds and large institutions have $5.22K invested in InVivo Therapeutics Holdings Corp in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
71% less funds holding
Funds holding: 14 → 4 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
92% less capital invested
Capital invested by funds: $68.3K → $5.22K (-$63.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$15.2K |
| 2 |
Barclays
London,
United Kingdom
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$25.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.13K |
| 5 |
Morgan Stanley
New York
|
-$394 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $5.22K | +$15.2K | +23,741 | New |
|
|
VL
2
Vima LLC
Troy,
Michigan
| $2 | – | – | – |
|
|
3
BlackRock
New York
| – | -$25.3K | -34,714 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$22.8K | -31,238 | Closed |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$13.6K | -18,677 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$6.13K | -8,395 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$394 | -540 | Closed |
|
8
Wells Fargo
San Francisco,
California
| – | -$18 | -24 | Closed |
|
9
Osaic Holdings
Scottsdale,
Arizona
| – | -$3 | -5 | Closed |
|
|
CTA
10
Colonial Trust Advisors
Spartanburg,
South Carolina
| – | -$1 | -2 | Closed |
|
|
ITIM
11
Indiana Trust & Investment Management
Mishawaka,
Indiana
| – | -$1 | -2 | Closed |
|
|
AF
12
Allworth Financial
Folsom,
California
| – | -$1 | -1 | Closed |
|
|
PWA
13
Provenance Wealth Advisors
Fort Lauderdale,
Florida
| – | -$1 | -1 | Closed |
|
14
UBS Group
Zurich,
Switzerland
| – | -$1 | -1 | Closed |
|
|
15
Barclays
London,
United Kingdom
| – | +$1 | +2 | New |
|
NVIV Hedge Fund Activity: Q1 2024 in Review
4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2024, worth a combined $5.22K — down 92% from $68.3K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NVIV and 2 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $15.2K. The largest seller was BlackRock, exiting entirely with an estimated $25.3K sold.
- 4 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2024, down from 14 in Q4 2023.
- Funds reported $5.22K of InVivo Therapeutics Holdings Corp stock for Q1 2024, down 92% quarter-over-quarter.
- 2 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2024 and 12 closed out, a net change of -10 holders.
- The largest InVivo Therapeutics Holdings Corp buyer in Q1 2024 was Goldman Sachs, an estimated $15.2K added.
- The largest InVivo Therapeutics Holdings Corp seller in Q1 2024 was BlackRock, an estimated $25.3K sold.
Based on aggregated 13F filings for Q1 2024.